Evento
Asymmetric dimethylarginine (adma) inhibits the effect of erythropoietin on endothelial cell migration in a proinflammatory environment
Chamorro, María Eugenia
; Maltaneri, Romina Eugenia
; Schiappacasse, Agustina
; Vittori, Daniela Cecilia
; Nesse, Alcira Beatriz
Tipo del evento:
Reunión
Nombre del evento:
LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio
Fecha del evento:
13/11/2019
Institución Organizadora:
Sociedad Argentina de Investigación Clínica;
Asociación Argentina de Farmacología Experimenta;
Sociedad Argentina de Biología;
Sociedad Argentina de Protozoología;
Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio;
Asociación Argentina de Nanomedicinas;
Título de la revista:
Medicina (Buenos Aires)
Editorial:
Fundación Revista Medicina
Idioma:
Inglés
Clasificación temática:
Resumen
Hyperhomocysteinemia induces vascular endothelial dysfunction, an early hallmark of atherogenesis. Previously, we found a sensitizing effect of the inflammatory cytokine TNF-alpha on a promigratory action of erythropoietin (Epo), which was not observed when the molecule was modified by N-homocysteinylation with homocysteine thiolactone, the reactive derivative of homocysteine. The strong correlation found between hyperhomocysteinemia and levels of asymmetric dimethylarginine (ADMA), the amino acid formed during methylation of proteins, has been considered of interest in endothelial dysfunction. Therefore, the aim of this work was to study whether ADMA accumulation could affect the ability of different factors to induce endothelial cell migration. Wound healing assays of EA.hy926 endothelial cells stimulated by 10% fetal bovine serum (FBS), 20 ng/mL VEGF or Epo+TNF-alpha (80 ng/mL and 30 ng/mL, respectively) were performed in the presence or absence of ADMA (30 or 100 µM). Results are expressed as a percentage of the cell migration obtained in the presence of FBS. FBS: 100; Control: 22.0±2.4; ADMA: 20.1±3.4; *FBS+ADMA30: 66.6±3.5; **FBS+ADMA100: 43.3±3.9; Epo+TNF-alpha: 56.4±1.2; *Epo+TNF-alpha+ADMA30: 37.4±2.9; **Epo+TNF-alpha+ADMA100: 31.1±1.6; VEGF: 44.5±2.9; *VEGF+ADMA30: 30.3±2.1; **VEGF+ADMA100: 19.6±2.8; *P<0.05 and **P<0.01 vs. respective controls, n=4. It can be seen that the inhibition of the promigratory effects of all the factors analyzed was dependent on ADMA concentration. The results of cell viability and MTT assays confirmed that the effects of ADMA on the promigratory action of Epo+TNF-alpha and VEGF cannot be attributed to cytotoxicity or cell proliferation. These results underline the important role of homocysteine in cardiovascular pathophysiology, since increased homocysteine is involved in a direct inhibition of the enzymes responsible for ADMA degradation.
Archivos asociados
Licencia
Identificadores
Colecciones
Eventos(IQUIBICEN)
Eventos de INSTITUTO DE QUIMICA BIOLOGICA DE LA FACULTAD DE CS. EXACTAS Y NATURALES
Eventos de INSTITUTO DE QUIMICA BIOLOGICA DE LA FACULTAD DE CS. EXACTAS Y NATURALES
Citación
Asymmetric dimethylarginine (adma) inhibits the effect of erythropoietin on endothelial cell migration in a proinflammatory environment; LXIV Reunión Anual de la Sociedad Argentina de Investigación Clínica; LI Reunión Anual de la Asociación Argentina de Farmacología Experimental; XXI Reunión Anual de la Sociedad Argentina de Biología; XXXI Reunión Anual de la Sociedad Argentina de Protozoología; IX Reunión Anual de la Asociación Argentina de Nanomedicinas y VI Reunión Científica Regional de la Asociación Argentina de Ciencia y Tecnología de Animales de Laboratorio; Mar del Plata; Argentina; 2019; 1-1
Compartir